The role of drug transporters in the kidney: lessons from tenofovir
about
Integrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo AcidsDrug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic StudyA Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 InfectionEffect of changing from first- to second-line antiretroviral therapy on renal function: a retrospective study based on data from a single health facility in Namibia.Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use.Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202Organic Cation Transporter 2 Overexpression May Confer an Increased Risk of Gentamicin-Induced Nephrotoxicity.Development and Application of Human Renal Proximal Tubule Epithelial Cells for Assessment of Compound Toxicity.Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults.Class-specific relative genetic contribution for key antiretroviral drugs.Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics.Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate.Severe hypokalemia due to a possible drug-drug interaction between vinblastine and antiretrovirals in a HIV-infected patient with Hodgkin's lymphoma.Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines.Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics.An Optimized Method for Protein Extraction from OCT-Embedded Human Kidney Tissue for Protein Quantification by LC-MS/MS Proteomics.Pharmacogenetic considerations for HIV treatment in different ethnicities: an update.What do we know about tailoring treatment with tenofovir?
P2860
Q26800036-FCFAB1BE-8A98-4793-8BF6-13DCBFAE7701Q28550681-DEF73D76-FD93-4FEC-8D89-DAEAEEBD8B2DQ28552839-BE827503-70AA-4568-B49B-5AE5A5249CEDQ31108490-9512D31C-F181-4640-BA78-D1CAD97B34CBQ34478840-DC326F9E-9B79-4CAA-B089-615F75A2FDDFQ35908584-F133B217-B2B5-4DE9-8C86-746251E5034DQ37203854-547D8059-2E0A-46D9-8ADD-5C26411DCB92Q37717456-6ACA7AA5-7773-4B91-8E19-EFA6667D8103Q38661064-C57A74B1-BC09-46DD-9C6A-3B7C8B06932BQ38980007-C001C859-8285-47E9-BEF4-0E60F72DFBAAQ39398250-6DC75688-6E34-48D4-A4BD-E108D0DB8F54Q40099241-0D76EA09-87D2-4BAA-93A2-4EFA845E2FCAQ40253793-1CACCA89-0A54-4E29-B055-1C7F4E853665Q40462001-8F569EFB-79C2-4271-879E-C1F2C090376FQ41048998-AAF75844-3B6E-4D08-9DD1-B76C36CF4B85Q41640455-050AAA3B-4E40-42F9-9557-11265DF8B363Q47906608-5C57C58E-69F6-4DBA-A24D-5AC260438F84Q54624919-BADC2527-6417-4B7F-AB5C-C45DC2CFD47F
P2860
The role of drug transporters in the kidney: lessons from tenofovir
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The role of drug transporters in the kidney: lessons from tenofovir
@ast
The role of drug transporters in the kidney: lessons from tenofovir
@en
The role of drug transporters in the kidney: lessons from tenofovir
@nl
type
label
The role of drug transporters in the kidney: lessons from tenofovir
@ast
The role of drug transporters in the kidney: lessons from tenofovir
@en
The role of drug transporters in the kidney: lessons from tenofovir
@nl
prefLabel
The role of drug transporters in the kidney: lessons from tenofovir
@ast
The role of drug transporters in the kidney: lessons from tenofovir
@en
The role of drug transporters in the kidney: lessons from tenofovir
@nl
P2860
P50
P356
P1476
The role of drug transporters in the kidney: lessons from tenofovir
@en
P2093
Darren M. Moss
P2860
P356
10.3389/FPHAR.2014.00248
P407
P577
2014-11-11T00:00:00Z